Literature DB >> 18077483

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.

Gabor Z Duray1, Carsten W Israel, Dimitrij Pajitnev, Stefan H Hohnloser.   

Abstract

AIMS: Cardiac resynchronization therapy (CRT) is indicated in patients with heart failure and bundle branch block. It is less clear whether this includes patients with pre-existing right ventricular pacemaker/defibrillator systems, particularly with respect to implantation success and clinical benefit. METHODS AND
RESULTS: In consecutive patients scheduled for CRT, we prospectively compared implantation success, procedural parameters, and clinical response in 'de novo' vs. upgrade procedures of previously implanted right ventricular systems. CRT implantation was attempted in 79 consecutive patients (64 +/- 11 years, 63 male, 38 ischaemic, 41 non-ischaemic cardiomyopathy). De novo implantation was performed in 61 patients, upgrade procedures in 18 patients. Implant success (92 vs. 94%, P = 1.00), procedure duration (153 +/- 43 vs. 164 +/- 65 min, P = 0.51), fluoroscopy time (25 +/- 18 vs. 32 +/- 22 min, P = 0.18) or dose (40 +/- 31 vs. 52 +/- 49 Gy/cm(2), P = 0.35), and response rate (66 vs. 59%, P = 0.5) were comparable for both groups.
CONCLUSION: Procedural aspects, implantation success, and clinical response to CRT were comparable for patients undergoing de-novo vs. upgrade procedures. Accordingly, patient selection for upgrading should be the same as for new CRT implantation.

Entities:  

Mesh:

Year:  2007        PMID: 18077483     DOI: 10.1093/europace/eum259

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Selective site pacing: rationale and practical application.

Authors:  Sameer Parekh; Kenneth M Stein
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

Review 2.  [Upgrading to biventricular pacing: indications and procedural challenges].

Authors:  H-H Minden; C Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-12

3.  Transesophageal left ventricular electrogram-recording and temporary pacing to improve patient selection for cardiac resynchronization.

Authors:  Matthias Heinke; Bruno Ismer; Helmut Kühnert; Hans R Figulla
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

4.  QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy.

Authors:  John Rickard; Alan Cheng; David Spragg; Daniel Cantillon; Mina K Chung; W H Wilson Tang; Bruce L Wilkoff; Niraj Varma
Journal:  Heart Rhythm       Date:  2012-09-18       Impact factor: 6.343

5.  Non-infective left ventricular lead complications requiring re-intervention following cardiac resynchronization therapy: prevalence, causes and outcomes.

Authors:  Christoffer Tobias Witt; Marie Jennyfer Ng Kam Chuen; Mads Brix Kronborg; Jens Kristensen; Christian Gerdes; Jens Cosedis Nielsen
Journal:  J Interv Card Electrophysiol       Date:  2021-02-01       Impact factor: 1.900

6.  De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis.

Authors:  Annamaria Kosztin; Mate Vamos; Daniel Aradi; Walter Richard Schwertner; Attila Kovacs; Klaudia Vivien Nagy; Endre Zima; Laszlo Geller; Gabor Zoltan Duray; Valentina Kutyifa; Bela Merkely
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

7.  Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy.

Authors:  Bogdan Beca; John L Sapp; Martin J Gardner; Christopher Gray; Amir AbdelWahab; Ciorsti MacIntyre; Steve Doucette; Ratika Parkash
Journal:  CJC Open       Date:  2019-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.